Sleep reactivity as a novel mechanism in Shift Work Disorder

睡眠反应性是轮班工作障碍的一种新机制

基本信息

  • 批准号:
    10530756
  • 负责人:
  • 金额:
    $ 76万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-15 至 2027-08-31
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract All essential 24-hr operations (e.g., first responders, hospital services) rely on nightshift workers who forgo nocturnal sleep for work. Shift workers comprise 20% of the workforce, with 15 million regularly working nights. Most do not adapt to the inverted sleep-wake schedule, resulting in shift work disorder (SWD) characterized by excessive sleepiness and/or insomnia with sleep loss. Furthermore, because nightshifts are critical to safety- sensitive operations, the risk for catastrophic accidents makes SWD a threat to public health and safety. There remain critical gaps in the clinical translation of shift work research into validated treatments for SWD. One gap is a lack of mechanistic research in large clinical samples of SWD that probe pertinent treatment targets. As such, treatments have predominantly focused on symptom management (e.g., stimulants to maintain alertness and hypnotic medications for sleep). Symptom management alone leaves the underlying mechanisms unabated which can continue to cause a myriad of acute and long-term problems and morbidities. To address this gap, the overall objective of this proposal is to elucidate critical and novel mechanisms driving SWD. Our long-term goal is to develop a treatment that identifies and targets the appropriate underlying mechanisms in SWD. Our pilot data indicates that in addition to circadian misalignment (i.e., a mismatch between the body- clock and the sleep-work schedule), one novel and critical mechanism in SWD is sleep reactivity. Sleep reactivity is a trait where sleep is easily disrupted by environmental stimuli and stressors. Our pilot data in a cross-sectional sample suggests that sleep reactivity predicts persistent SWD symptoms even after reducing circadian misalignment. We also show that sleep reactivity can be reduced with Cognitive Behavioral Therapy (CBT). However, sleep reactivity has not been experimentally disassociated from circadian misalignment as an independent causal mechanism of SWD. This research is critical because it would demonstrate that SWD treatment should target sleep reactivity independently from circadian misalignment. To do this, we propose a two-step mechanistic randomized controlled trial in SWD stratified by high and low sleep reactivity (N=150): the first step probes circadian misalignment using timed bright light exposure, and the second step reduces sleep reactivity with Cognitive Behavioral Therapy. Our central hypothesis is that symptoms of SWD will reduce proportionately with circadian realignment in SWD with low sleep reactivity; however, both insomnia (Aim 1) and sleepiness (Aim 2) symptoms will persist in SWD with high sleep reactivity even after experimental reduction of circadian misalignment. In those with persistent symptoms despite reduced circadian misalignment, further reducing sleep reactivity with CBT would result in reductions in symptoms (Aims 3 & 4). Upon completion, results from this study will have established sleep reactivity as a novel causal mechanism of SWD to be inform future precision medicine approaches for this highly prevalent and undertreated disorder.
项目总结/摘要 所有基本的24小时操作(例如,急救人员、医院服务)依赖于放弃的夜班工人 夜间睡眠工作。轮班工人占劳动力的20%,有1500万人经常上夜班。 大多数人不适应颠倒的睡眠-觉醒时间表,导致轮班工作障碍(SWD),其特征是 过度嗜睡和/或失眠伴睡眠不足。此外,由于夜班对安全至关重要- 由于社署的运作敏感,发生灾难性意外的风险,令社署对公众健康和安全构成威胁。那里 在将轮班工作研究转化为有效的社会福利署治疗方法的临床转化方面仍然存在关键差距。一个间隙 缺乏对SWD大样本临床研究的机制研究,以探索相关的治疗靶点。作为 这样的治疗主要集中在症状管理(例如,保持警觉的兴奋剂 催眠药物(用于睡眠)。症状管理本身留下了潜在的机制 其可继续引起无数急性和长期问题和发病率。解决 这个差距,这一建议的总体目标是阐明关键和新的机制,推动社会福利署。我们 长期目标是开发一种治疗方法,识别并靶向适当的潜在机制, SWD.我们的试验数据表明,除了昼夜节律失调(即,身体和身体之间的不匹配 时钟和睡眠-工作时间表),SWD中的一个新的和关键的机制是睡眠反应性。睡眠 反应性是睡眠容易被环境刺激和紧张性刺激破坏的特征。我们的试点数据在一个 横断面样本表明,睡眠反应预测持续的SWD症状,即使在减少 昼夜节律失调我们还表明,睡眠反应可以减少与认知行为疗法 (CBT)。然而,睡眠反应性还没有被实验性地从昼夜节律失调中分离出来, 社署的独立因果机制。这项研究是至关重要的,因为它将证明, 治疗应该针对睡眠反应性,而不依赖于昼夜节律失调。为此,我们提出了一个 两步机械随机对照试验在SWD分层的高和低睡眠反应(N=150): 第一步使用定时强光照射探测昼夜节律失调,第二步减少睡眠 认知行为疗法的反应。我们的中心假设是, 与睡眠反应性低的SWD的昼夜节律重新调整成比例;然而,失眠(目的1) 和嗜睡(目标2)的症状将持续存在,即使在实验后, 减少昼夜节律失调。在那些尽管昼夜节律降低但症状持续的患者中, 如果不对准,进一步降低CBT的睡眠反应性将导致症状的减少(目的3&4)。 完成后,这项研究的结果将建立睡眠反应作为一种新的因果机制, 社署将告知未来的精确医学方法,以治疗这种高度流行和治疗不足的疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Philip Cheng其他文献

Philip Cheng的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Philip Cheng', 18)}}的其他基金

Assessment of mobile application-delivered lighting interventions for reducing circadian disruption in shift workers
评估移动应用程序提供的照明干预措施,以减少轮班工人的昼夜节律紊乱
  • 批准号:
    10384670
  • 财政年份:
    2022
  • 资助金额:
    $ 76万
  • 项目类别:
Sleep reactivity as a novel mechanism in Shift Work Disorder
睡眠反应性是轮班工作障碍的一种新机制
  • 批准号:
    10704676
  • 财政年份:
    2022
  • 资助金额:
    $ 76万
  • 项目类别:
Enhancing digital CBT-I to improve adherence and reduce disparities
增强数字 CBT-I 以提高依从性并减少差异
  • 批准号:
    10279108
  • 财政年份:
    2021
  • 资助金额:
    $ 76万
  • 项目类别:
Enhancing digital CBT-I to improve adherence and reduce disparities
增强数字 CBT-I 以提高依从性并减少差异
  • 批准号:
    10686072
  • 财政年份:
    2021
  • 资助金额:
    $ 76万
  • 项目类别:
Enhancing digital CBT-I to improve adherence and reduce disparities
增强数字 CBT-I 以提高依从性并减少差异
  • 批准号:
    10491349
  • 财政年份:
    2021
  • 资助金额:
    $ 76万
  • 项目类别:
Clinical translation of phenotypes of shift work disorder
轮班工作障碍表型的临床转化
  • 批准号:
    10208934
  • 财政年份:
    2017
  • 资助金额:
    $ 76万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 76万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 76万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 76万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 76万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 76万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 76万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 76万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 76万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 76万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 76万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了